Abstract
Objectives
The objective of this study was to analyze the predictive value of the modified Bhalla score in high-resolution computed tomography (HRCT) for assessment of pulmonary exacerbations (PEx) in cystic fibrosis (CF) patients. We also describe the relationship between this score and pulmonary function test results.
Methods
We performed a multicenter and prospective study where adult patients with CF were included consecutively over 18 months. All patients underwent HRCT with acquisition in inspiration and expiration. The results were analyzed by an expert radiologist who assigned a modified Bhalla score value. Lung function was also assessed, and clinical variables were collected. Follow-up lasted approximately 1 year, and PEx were registered.
Results
The study population comprised 160 subjects selected from 360 CF patients monitored in the participating CF units. The mean age was 28 years, 47.5% were women, and mean forced expiratory volume in 1 s (FEV1) was 67.5%. The mean global modified Bhalla score was 14.5 ± 0.31 points. Pulmonary function test (PFT) results and the modified Bhalla score correlated well, mainly forced vital capacity (FVC) and FEV1. We constructed a statistical model based on the overall Bhalla score to predict the number of PEx.
Conclusions
The overall modified Bhalla score can predict future PEx in CF patients. This useful tool can help to prevent PEx in higher risk patients.
Key Points
• Pulmonary function test results and the modified Bhalla score correlated well with FVC and FEV1.
• The total modified Bhalla score can predict the number of exacerbations in adult CF patients.
• Our findings highlight the need to establish a unified protocol for chest HRCT during the follow-up of adult patients with CF in order to anticipate possible complications and determine their impact on pulmonary function.
Similar content being viewed by others
References
Salcedo-Posadas A, Gartner S, Girón-Moreno RM, García-Novo MD (2012) Tratado de Fibrosis Quística. Justim, Madrid
Jong P, Nakano Y, Lequin MH, Mayo JR, Woods R, Dare P et al (2004) Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis. Eur Respir J 23:93–97
Loeve M, Gerbrands K, Hop W, Rosenfeld M, Hartmann I, Tiddens H (2011) Bronchiectasis and pulmonary exacerbations in children and young adults with cystic fibrosis. Chest 140(1):178–115
Pettit RS, Fellner C (2014) CFTR modulators for the treatment of cystic fibrosis. P T 39(7):500–511
Davies J, Alton E (2009) Monitoring respiratory disease severity in cystic fibrosis. Respir Care 54(5):606–615
Loeve M, Hop W, Bruijne M (2012) Chest computed tomography scores are predictive of survival in patients with cystic fibrosis awaiting lung transplantation. Am J Respir Crit Care Med 185(10):1096–1103
Demirkazık FB, Ariyurek OM, Ozcelik U, Gocmen A, Hassanabd HK, Kiper N (2001) High resolution CT in children with cystic fibrosis: correlation with pulmonary functions and radiographic scores. Eur J Radiol 37:54–59
Justicia JL, Solé A, Quintana-Gallego E et al (2015) Management of pulmonary exacerbations in cystic fibrosis: still an unmet medical need in clinical practice. Expert Rev Respir Med 9(2):183–194
Tepper L, Utens E, Caudri D et al (2013) Impact of bronchiectasis and trapped air on quality of life and exacerbations in cystic fibrosis. Eur Respir J 42:371–379
Kilcoyne A, Lavelle P, McCarthy CJ et al (2016) Chest CT abnormalities and quality of life: relationship in adult cystic fibrosis. Ann Transl Med 4(5):87
Barrio MI, García G, Gartner S y Grupo de trabajo de Fibrosis Quística (2009) Protocol for the diagnosis and follow up of patients with cystic fibrosis. An Pediatr (Barc) 71(3):250–264
Máiz L, Baranda F, Coll R et al (2001) SEPAR (Spanish Society of Pneumology and Thoracic Surgery) Guidelines. Guideline for diagnosis and treatment of respiratory involvements in cystic fibrosis. Arch Bronconeumol 37:316–324
Cantón R, Máiz L, Escribano A et al (2015) Spanish consensus on the prevention and treatment of Pseudomonas aeruginosa bronchial infections in cystic fibrosis patients. Arch Bronconeumol 51(3):140–150
Cademartiri F, Luccichenti G, Palumbo AA et al (2008) Predictive value of Chest CT in patients with cystic fibrosis: a single center 10-year experience. AJR Am J Roentgenol 190:1475–1480
Bhalla M, Turcios N, Aponte V et al (1991) Cystic fibrosis: scoring system with thin-section CT. Radiology 179:783–788
Albi G, Rayón-Aledo JC, Caballero P, Rosado P y García-Esparza E (2012) Cystic fibrosis in images: the Bhalla scoring system for computed tomography in paediatric patients. Radiología. 54(3):260–268
Ibrahim M, Elborn J, Rendall J, Parkins M (2010) Clinical features and outcomes of cystic fibrosis pulmonary exacerbations presenting with normal inflammatory markers. J Cyst Fibros S56
Schechter M (2018) Reevaluating approaches to cystic fibrosis pulmonary exacerbations. Pediatr Pulmonol 53(S3):S51–S63
Girón-Moreno RM, Justicia JL, Yamamoto S et al (2014) Role of C-reactive protein as a biomarker for prediction of the severity of pulmonary exacerbations in patients with cystic fibrosis. BMC Pulm Med 14:150
Rabin HR, Butler SM, Wohl ME et al (2004) Epidemiologic study of cystic fibrosis. Pulmonary exacerbations in cystic fibrosis. Pediatr Pulmonol 37(5):400–406
Martínez González MA, Faulin FJ, Sánchez A (2014) Bioestadística amigable. 3° edición. Elsevier, Spain
Horsley A, Siddiqui S (2015) Putting lung function and physiology into perspective: cystic fibrosis in adults. Respirology 20(1):33–45
Judge EP, Dodd JD, Masterson JB, Gallagher CG (2006) Pulmonary abnormalities on high-resolution CT demonstrate more rapid decline than FEV1 in adults with cystic fibrosis. Chest 130:1424–1432
Brody AS, Sucharew H, Campbell JD et al (2005) Computed tomography correlates with pulmonary exacerbations in children with cystic fibrosis. Am J Respir Crit Care Med 172(9):1128–1132
Loeve M, van Hal P, Robinson P et al (2009) The spectrum of structural abnormalities on CT scans from patients with CF with severe advanced lung disease. Thorax 64:876–882
Sanders DB, Li Z, Brody AS (2015) Chest computed tomography predicts the frequency of pulmonary exacerbations in children with cystic fibrosis. Ann Am Thorac Soc 12(1):64–69
Tiddens H, Puderbach M, Venegas J et al (2015) Novel outcome measures for clinical trials in cystic fibrosis. Pediatr Pulmonol 50:302–315
Funding
This study has received funding by “Beca ayuda a la investigación SEPAR.”
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Layla Diab Cáceres.
Conflict of interest
The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
Statistics and biometry
One of the authors has significant statistical expertise (Maria Teresa Pastor Sanz).
Informed consent
Written informed consent was obtained from all subjects (patients) in this study.
Ethical approval
Institutional Review Board approval was obtained.
Methodology
• prospective
• observational
• multicenter study
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Diab-Cáceres, L., Girón-Moreno, R.M., García-Castillo, E. et al. Predictive value of the modified Bhalla score for assessment of pulmonary exacerbations in adults with cystic fibrosis. Eur Radiol 31, 112–120 (2021). https://doi.org/10.1007/s00330-020-07095-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-020-07095-y